BOLD
Boundless Bio, Inc.
2.46
+0.01 (+0.41%)
52w low 0.9610
3.16 high
68.0% of range
Financial Analysis
| Ratio | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| Return on Equity | -- | -12.8% | -12.6% | -13.1% | -15.7% | -35.9% | |
| Return on Assets | -- | -8.7% | -8.2% | -8.2% | -9.6% | -32.1% | |
| Return on Inv Capital | -- | -11.0% | -10.9% | -11.2% | -13.2% | -29.2% | |
| Liquidity | |||||||
| Current Ratio | -- | 14.08x | 10.14x | 8.74x | 9.87x | 9.48x | |
| Quick Ratio | -- | 14.08x | 10.14x | 8.74x | 9.87x | 9.48x | |
| Cash Ratio | -- | 1.60x | 1.26x | 1.43x | 1.82x | 2.60x | |
| Leverage | |||||||
| Debt / Equity | -- | 0.40x | 0.45x | 0.50x | 0.56x | 0.00x | |
| Equity Multiplier | -- | 1.46x | 1.53x | 1.59x | 1.63x | 1.12x | |
| Efficiency | |||||||
| Asset Turnover | -- | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | |
| Op CF / Net Income | -- | 0.75x | 0.73x | 0.78x | 1.10x | 0.89x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--